Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Molecular therapy for Cancer: Anti-cancer drug Campothecin (CPT) suppresses the expression of oncogenic Zinc finger protein 217 (ZNF217) via down regulation of its target gene, 29/January/2015, 22.37, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests that Campothecin (CPT), by increasing the expression of its target gene, it may suppress the expression of ZNF217. Thus, pharmacological formulations encompassing “Campothecin or its analogues“ may be used to inhibit the progression of tumors.
Amount: $ 200
Undisclosed information: How Campothecin (CPT) suppresses the expression of ZNF217
Courtesy: When you cite drop us a line at firstname.lastname@example.org